Journal of Comprehensive Pediatrics

Published by: Kowsar

Impact of N-myc Amplification on Median Survival in Children With Neuroblastoma

Mohammad Pedram 1 , * , Morteza Heidari 2 , Bijan Keikhaei 1 , Reza Azizi Malamiri 2 , Behzad Poopak 3 and Kiavash Fekri 4
Authors Information
1 Thalassemia and Hemoglobinopathy, Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Pediatrics, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Medical Sciences, Tehran Islamic Azad University of Medical Sciences, Tehran, IR Iran
4 Department of Pediatric, Shafa Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 01, 2012, 3 (1); 29-33
  • Published Online: August 14, 2012
  • Article Type: Research Article
  • Received: July 15, 2011
  • Revised: January 22, 2012
  • Accepted: April 2, 2012
  • DOI: 10.17795/compreped-7273

To Cite: Pedram M, Heidari M, Keikhaei B, Azizi Malamiri R, Poopak B, et al. Impact of N-myc Amplification on Median Survival in Children With Neuroblastoma, J Compr Ped. 2012 ; 3(1):29-33. doi: 10.17795/compreped-7273.

Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Young JL, Jr., Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986; 58(2 Suppl): 598-602
  • 2. Castleberry RP. Neuroblastoma. Eur J Cancer. 1997; 33(9): 1430-7[DOI]
  • 3. Evans AE, D’Angio GJ, Randolph J. A proposed staging for children with neuroblastoma. Children’s cancer study group A. Cancer. 1971; 27(2): 374-84
  • 4. Brodeur GM, Castleberry RP. 1997; : 761-97
  • 5. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol. 1995; 24(4): 215-21[DOI][PubMed]
  • 6. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984; 311(4): 231-5[DOI][PubMed]
  • 7. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993; 328(12): 847-54[DOI][PubMed]
  • 8. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984; 224(4653): 1121-4[DOI][PubMed]
  • 9. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985; 313(18): 1111-6[DOI][PubMed]
  • 10. Alitalo K, Schwab M. Oncogene amplification in tumor cells. Adv Cancer Res. 1986; 47: 235-81[DOI]
  • 11. Pession A, Trere D, Perri P, Rondelli R, Montanaro L, Mantovani W, et al. N-myc amplification and cell proliferation rate in human neuroblastoma. J Pathol. 1997; 183(3): 339-44
  • 12. de Cremoux P, Thioux M, Peter M, Vielh P, Michon J, Delattre O, et al. Polymerase chain reaction compared with dot blotting for the determination of N-myc gene amplification in neuroblastoma. Int J Cancer. 1997; 72(3): 518-21
  • 13. Sestini R, Orlando C, Zentilin L, Gelmini S, Pinzani P, Bianchi S, et al. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. Clin Chem. 1994; 40(4): 630-6[PubMed]
  • 14. Sestini R, Orlando C, Zentilin L, Lami D, Gelmini S, Pinzani P, et al. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template. Clin Chem. 1995; 41(6 Pt 1): 826-32[PubMed]
  • 15. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett JE, Roberts WM, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol. 1993; 142(5): 1339-46[PubMed]
  • 16. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Mol Cell Probes. 1993; 7(3): 227-34[DOI][PubMed]
  • 17. Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol. 1998; 16(6): 2007-17[PubMed]
  • 18. Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. J Clin Oncol. 2004; 22(24): 4888-92[DOI][PubMed]
  • 19. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol. 1997; 15(3): 1171-82[PubMed]
  • 20. Sansone R, Strigini P, Badiali M, Dominici C, Fontana V, Iolascon A, et al. Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience. Cancer Genet Cytogenet. 1991; 54(2): 253-7[DOI]
  • 21. Christiansen H, Sahin K, Berthold F, Hero B, Terpe HJ, Lampert F. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer. 1995; 31A(4): 541-4[DOI]
  • 22. Raggi CC, Bagnoni ML, Tonini GP, Maggi M, Vona G, Pinzani P, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem. 1999; 45(11): 1918-24[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments